FDA Adverse Event Death Summary report: N

MAXIMO II VR

MDR report key: 4960352 · Received August 3, 2015

Report

Report Number
9614453-2015-01642
Event Type
Death
Date Received
August 3, 2015
Date of Event
June 21, 2015
Report Date
July 9, 2015
Manufacturer
IPG MFG SWITZERLAND
Product Code
LWS
PMA / PMN Number
P980016
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED OUTSIDE THE US WHERE THE SAME MODEL IS DISTRIBUTED. ALL INFORMATION PROVIDED IS INCLUDED IN THIS REPORT. PATIENT INFORMATION IS NOT GENERALLY AVAILABLE DUE TO CONFIDENTIALITY CONCERNS. (B)(4).

Additional Manufacturer Narrative · 1

PRODUCT EVENT SUMMARY: THE DEVICE WAS RETURNED, ANALYZED AND NO ANOMALIES WERE FOUND. PATIENT DEATH GEO EVENT DESCRIPTION: IT WAS REPORTED THAT THE PATIENT, WITH MAXIMO II VR DEVICE, PASSED AWAY AROUND (B)(6). THE PATIENT COULD HAVE DIED DUE TO SEVER GASPING AND BREATHLESSNESS WHEN HE REACHED HOSPITAL AND SUDDENLY DIED. IT WAS QUESTIONED WHAT COULD HAVE BEEN THE REASON FOR DEATH OF THIS PATIENT WHILE PATIENT WAS HAVING DEVICE. THE DEVICE WAS NOT SWITCHED OFF AT THE TIME OF EXPLANT. PRELIMINARY GEO ASSESSMENT: REVIEW OF STD ((B)(6) 2015) REVEALED: THIS PATIENT WAS NOT PACING DEPENDENT (0% PACING/DAY). PACING STARTED ON (B)(6) 2015 AT APPROXIMATELY 4:56 H. ONE SHOCK WAS SUCCESSFULLY DELIVERED AT 4:28 H. MULTIPLE NON-SUCCESSFUL SHOCKS WERE DELIVERED AT 4:57 H. EGM RECORDINGS WERE OVER-WRITTEN AND CANNOT BE RECOVERED. NO PATIENT ALERTS: NORMAL IMPEDANCES PRELIMINARY GEO CONCLUSION: SUSPECT SYSTEM OK (B)(4).

Additional Manufacturer Narrative · 1

A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT EXPIRED APPROXIMATELY EIGHT MONTHS AFTER IMPLANT OF THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD). THE PATIENT PRESENTED WITH "SEVERE GASPING AND BREATHLESSNESS WHEN HE REACHED HOSPITAL AND SUDDENLY DIED." THE EXACT CAUSE OF DEATH WAS REQUESTED BUT REMAINS UNCLEAR. IT WAS NOTED THAT DEVICE DETECTIONS WERE NOT TURNED OFF AT THE TIME OF DEVICE EXPLANT, OVER-WRITING DEVICE DATA THAT WAS RECORDED AT THE TIME OF DEATH.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
504163 MAXIMO II VR DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER LWS IPG MFG SWITZERLAND D284VRC

Patients

Seq Age Sex Outcome Treatment
1 Death